iCreatAI News
Skip to content
Trending storyUpdating

Estimate: How Much Validation Cost Would AI Need to Find Drugs for Every Fatal Disease?

1 reports1 sources23 hr agoUpdated

Understand this story

AI overview

An estimate proposes: assuming AI finds, for every fatal disease worldwide, a therapy that halves the risk of the worst outcome, and a single unified "benevolent coordinator" runs one pivotal trial for each disease, then the total cost of validating these therapies can be estimated at $53,904 per participant. That unit price comes from data by Moore et al. and is converted to 2026 dollars. The estimate covers only the pivotal trial costs under this scenario; the conclusion depends on the two premises of "one trial per disease" and a unified coordinator, and does not represent the full cost of actual R&D or approval.

AI overview based on source reports · Updated 23 hr ago

Coverage timeline

Follow the coverage to explore different perspectives.

Nov 21
  1. Hacker News AI
    If AI found better drugs for every disease, what would it cost to prove it?

    An analysis estimates the cost of pivotal trials to prove that, for every deadly disease in the Global Burden of Disease list, a new therapy halves the risk of the worst outcomes versus today's best care, using one trial per disease and Moore et al.'s median cost of $53,904 per participant (2026 dollars). The author was surprised the total was small relative to the roughly $100 billion the industry spent on phase 3 trials in 2024, attributing part of the gap to the large assumed effect size (today's best-care trials cut bad-outcome risk by a median of less than half) and part to redundancy, such as thousands of trials targeting PD-1/PD-L1. The piece suggests better-coordinated shared trial platforms, citing RECOVERY, I-SPY 2 and SEMATECH as models.

Activity for this story

Current comparable activity
5
Peak comparable activity
10Nov 21 09:00
Change in the past 24 hours
–

Trends compare the same fully observed participants, which may cover fewer participants than current activity. Move the pointer or tap the chart to inspect hourly activity; use the left and right arrow keys with a keyboard.